- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04502485
Reduce Patient Discomfort With Water Exchange Method During Upper Endoscopy
August 4, 2020 updated by: Yu-Hsi hsieh
The aim of the study was to evaluate the application of water exchange method to upper endoscopy.
We hypothesize that water exchange during upper endoscopy could reduce patient discomfort.
The primary outcome will be the patient discomfort score during upper endoscopy.
The secondary outcomes will include cleanliness score, techniques adequacy score, findings of the EGD, and willing to repeat the procedure, as well as the patient and endoscopist satisfaction score with the method.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
250
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Chiayi, Taiwan, 622
- Recruiting
- Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
-
Principal Investigator:
- Yu-Hsi Hsieh, MD
-
Contact:
- Yu-Hsi Hsieh, MD
- Phone Number: 5204 886052648000
- Email: hsiehyuhsi1112@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Eligible patients will include those anticipated to undergo EGD , aged 20 to 65 at the time of enrollment
Exclusion Criteria:
- a therapeutic EGD
- sedation with other agents
- American Society of Anesthesiology (ASA) risk Class 3 or higher, renal failure
- age less than 20 years or more than 65 years
- pregnancy
- refusal to provide written informed consent. All participants signed written informed consents
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Gastric water exchange
Air will be minimally insufflated to partially open the lumen and any residual fluid will be suctioned when the scope passes through the esophagus.
Upon entering the fundus of the stomach the air button will be turned off.
Air pocket and gastric fluids will be removed by suctioning.
Distilled water, delivered by a 50-ml syringe in 10ml-to-20 ml increments, will be infused to dislodge debris and air bubbles adhering the gastric mucosa and open the lumen.
The infused water will be removed to keep the lumen almost completely collapsed before the scope advance further.
Air will be opened when the scope enter the prepylorus area where there is usually an air pocket.
The scope will enter the duodenal bulb and 2nd portion of duodenum where withdrawal inspection will start.
|
Upon entering the fundus of the stomach the air button will be turned off.
Air pocket and gastric fluids will be removed by suctioning.
Distilled water, delivered by a 50-ml syringe in 10ml-to-20 ml increments, will be infused to dislodge debris and air bubbles adhering the gastric mucosa and open the lumen.
The infused water will be removed to keep the lumen almost completely collapsed before the scope advance further.
|
Active Comparator: Traditional air insufflation
Air will be minimally insufflated and residual fluid suctioned during the entire insertion process.
Usually, no water will be infused to cleanse the mucosa until the withdrawal phase.
|
Air will be minimally insufflated and residual fluid suctioned during the entire insertion process.
Usually, no water will be infused to cleanse the mucosa until the withdrawal phase.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Discomfort during the procedure
Time Frame: 5 minutes after the procedure
|
A VAS discomfort score (0, no discomfort; 10, most discomfort) graded by the patient,
|
5 minutes after the procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
patient satisfaction score
Time Frame: 5 minutes after the procedure
|
A VAS score (0, not satisfied at all; 10, most satisfied) graded by the patient
|
5 minutes after the procedure
|
mucosa cleanliness score
Time Frame: 1 minutes after the procedure
|
1, no need for irrigation; 4, need more than 50 ml of water irrigation
|
1 minutes after the procedure
|
technique adequacy score
Time Frame: 1 minutes after the procedure
|
1, excellent; 6, very poor
|
1 minutes after the procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Abraham N, Barkun A, Larocque M, Fallone C, Mayrand S, Baffis V, Cohen A, Daly D, Daoud H, Joseph L. Predicting which patients can undergo upper endoscopy comfortably without conscious sedation. Gastrointest Endosc. 2002 Aug;56(2):180-9. doi: 10.1016/s0016-5107(02)70175-2.
- Meining A, Semmler V, Kassem AM, Sander R, Frankenberger U, Burzin M, Reichenberger J, Bajbouj M, Prinz C, Schmid RM. The effect of sedation on the quality of upper gastrointestinal endoscopy: an investigator-blinded, randomized study comparing propofol with midazolam. Endoscopy. 2007 Apr;39(4):345-9. doi: 10.1055/s-2006-945195. Epub 2007 Feb 7.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2019
Primary Completion (Anticipated)
June 30, 2021
Study Completion (Anticipated)
June 30, 2021
Study Registration Dates
First Submitted
August 4, 2020
First Submitted That Met QC Criteria
August 4, 2020
First Posted (Actual)
August 6, 2020
Study Record Updates
Last Update Posted (Actual)
August 6, 2020
Last Update Submitted That Met QC Criteria
August 4, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- A10801002
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients Undergoing Diagnostic EGD
-
Dalin Tzu Chi General HospitalCompletedPatients Undergoing Diagnostic EGDTaiwan
-
Prof. Dr. med. Ingo EitelUnknownPatients Undergoing Diagnostic Coronary Angiography
-
NinePoint MedicalCompletedUndergoing Esophagogastroduodenoscopy (EGD)United States
-
NinePoint MedicalCompletedUndergoing Esophagogastroduodenoscopy (EGD)United States
-
The University of Hong KongUnknownPatients Undergoing Anesthesiologist-administered iv Sedation During Diagnostic/ Therapeutic ProceduresChina
-
Bracco Diagnostics, IncCompletedPatients Undergoing Contrast Enhanced Multidetector Computed Tomography of the Chest, Abdomen, Liver or Aorta for Any Diagnostic CauseUnited States, Italy
-
IRCCS SYNLAB SDNRecruitingSubjects Undergoing Diagnostic Imaging TestsItaly
-
University of LuebeckUnknownPatient Undergoing Diagnostic Coronary Angiography
-
Seoul National University HospitalHana Pharm Co., Ltd.CompletedUndergoing ERCP for Diagnostic or Therapeutic PurposesKorea, Republic of
-
Shaare Zedek Medical CenterUnknownPatients Undergoing Open Heart Surgery | Patients Undergoing Lung SurgeryIsrael
Clinical Trials on Gastric water exchange
-
Dalin Tzu Chi General HospitalCompletedColonoscopy | Intubation Time | Cap-assisted ColonoscopyTaiwan
-
Presidio Ospedaliero Santa BarbaraCompletedAbdominal PainUnited States, Czech Republic, Italy
-
VA Office of Research and DevelopmentCompletedColorectal NeoplasmsUnited States
-
Dalin Tzu Chi General HospitalCompletedAdenomaTaiwan, United States
-
Dalin Tzu Chi General HospitalCompleted
-
Dalin Tzu Chi General HospitalCompletedPain | Colon NeoplasmTaiwan
-
Dalin Tzu Chi General HospitalCompleted
-
Dalin Tzu Chi General HospitalSepulveda Ambulatory Care Center, VAGLAHSCompletedAdenomaUnited States, Taiwan
-
Evergreen General Hospital, TaiwanDigestive Endoscopy Unit, CTO Hospital, Iglesias, Italy; Digestive Endoscopy... and other collaboratorsRecruitingColonoscopy | Colon Adenoma | Colon PolypItaly, Taiwan
-
Yuqi HeRecruitingAdenoma and Polyp Detection RatesChina